Sphingolipidoses  >>  Goofice (elobixibat)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Goofice (elobixibat) / Ipsen
NCT01069783 / 2009-017878-21: Study of A3309 in Patients With Dyslipidemia

Completed
2
36
Europe
A3309, Placebo
Albireo
Dyslipidemia
09/10
09/10

Download Options